IL-17A Inhibitor Use Associated With Increased IBD Risk ...Middle East

Medscape - News
IL-17A Inhibitor Use Associated With Increased IBD Risk
The risk for inflammatory bowel disease is higher in patients with psoriasis or ankylosing spondylitis using IL-17A inhibitors than in those using apremilast, necessitating careful patient monitoring. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( IL-17A Inhibitor Use Associated With Increased IBD Risk )

Also on site :